Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gloria Ravegnini

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Epigenetics Insights|April 26, 2019
Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors: Small Steps Toward Personalized Medicine?Gloria Ravegnini, Riccardo Ricci
International Journal of Molecular Sciences|April 14, 2016
Toward Precision Medicine: How Far Is the Goal?Gloria Ravegnini, Sabrina Angelini
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Somatic pharmacogenomics of gastrointestinal stromal tumorGloria Ravegnini, Patrizia Hrelia, Sabrina Angelini
Expert Opinion on Drug Metabolism & Toxicology|May 6, 2016
Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemiaGloria Ravegnini, Giulia Sammarini, Sabrina Angelini, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 27, 2015
Key Genetic and Epigenetic Mechanisms in Chemical CarcinogenesisGloria Ravegnini, Gulia Sammarini, Patrizia Hrelia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2023
Correspondence on 'MicroRNA expression as a diagnostic parameter in early endometrial cancer' by Blagojević et alCamelia Alexandra Coada, Gloria Ravegnini, Anna Myriam Perrone
Cells|July 25, 2018
TRPM2 in the Brain: Role in Health and DiseaseGiulia Sita, Patrizia Hrelia, Agnese Graziosi, et al.
Pharmacogenomics|June 11, 2013
Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapySabrina Angelini, Gloria Ravegnini, Jonathan A Fletcher, et al.
Pharmacological Research|February 11, 2018
Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysisSarah Cargnin, Gloria Ravegnini, Simona Soverini, et al.
Frontiers in Endocrinology|September 6, 2021
GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in CancerCecilia Catellani, Gloria Ravegnini, Chiara Sartori, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Epigenetics Insights|April 26, 2019
Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors: Small Steps Toward Personalized Medicine?Gloria Ravegnini, Riccardo Ricci
International Journal of Molecular Sciences|April 14, 2016
Toward Precision Medicine: How Far Is the Goal?Gloria Ravegnini, Sabrina Angelini
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Somatic pharmacogenomics of gastrointestinal stromal tumorGloria Ravegnini, Patrizia Hrelia, Sabrina Angelini
Expert Opinion on Drug Metabolism & Toxicology|May 6, 2016
Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemiaGloria Ravegnini, Giulia Sammarini, Sabrina Angelini, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 27, 2015
Key Genetic and Epigenetic Mechanisms in Chemical CarcinogenesisGloria Ravegnini, Gulia Sammarini, Patrizia Hrelia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2023
Correspondence on 'MicroRNA expression as a diagnostic parameter in early endometrial cancer' by Blagojević et alCamelia Alexandra Coada, Gloria Ravegnini, Anna Myriam Perrone
Cells|July 25, 2018
TRPM2 in the Brain: Role in Health and DiseaseGiulia Sita, Patrizia Hrelia, Agnese Graziosi, et al.
Pharmacogenomics|June 11, 2013
Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapySabrina Angelini, Gloria Ravegnini, Jonathan A Fletcher, et al.
Pharmacological Research|February 11, 2018
Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysisSarah Cargnin, Gloria Ravegnini, Simona Soverini, et al.
Frontiers in Endocrinology|September 6, 2021
GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in CancerCecilia Catellani, Gloria Ravegnini, Chiara Sartori, et al.
Pageof 10